Drinking, Acetate, and Stress

Recruiting now · Not applicable

Conditions studied: Alcohol Use Disorder, Alcohol Use, Unspecified, Heavy Drinker, Alcohol Use Disorder, Moderate, in Sustained Remission

In brief

The purpose of this study is to learn how drinking alcohol affects how people experience stress and how that is affected by the body's chemistry. Specifically, the investigators will be studying relationships of drinking and a stress hormone called cortisol. The investigators believe that results will lead us to find more effective ways to help people stop or reduce drinking when participants are drinking at harmful levels.

Key facts

Study ID

NCT06584448

Run by

Yale University

People needed

50

Starts

2024-11-06

Expected to finish

2030-01-01

Last updated by the study team

2026-06-15

Who can join

Age: 18 and older, up to 55. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Provision of signed and dated informed consent form
• Stated willingness to comply with all study procedures and availability for the duration of the study
• Medically stable male or female, aged 18-55.
• Able to read, write and complete a multitude of self-assessments in English
• Meets DSM-5 criteria for current Alcohol Use Disorder (AUD)
• Participants who have Alcohol Use Disorder and are actively drinking must be willing to receive (at no cost) inpatient treatment for AUD for a period of up to 30 days. Participants who have been treated for an Alcohol Use Disorder and are now sober three months or longer will NOT be required to go inpatient.

You may not qualify if…

• Subjects with any significant current medical conditions (neurological, cardiovascular, endocrine, thyroid, renal, liver), seizures (for LTS subjects only- seizures directly related to alcohol detoxification are not an exclusion) , delirium or hallucinations, or other unstable medical conditions, including HIV.
• Current DSM-5 substance use disorder (other than AUD or tobacco use disorder)
• Any metallic objects implanted in their body which would make imaging unsafe (pacemaker, etc)
• Claustrophobia, or other inability to participate in an MRI
• A positive test result at intake appointment and subsequent appointments on urine drug screens conducted for illicit drugs. (Note: participants will not be paid for study visits if they test positive for an illicit drug and will be immediately excluded from study).
• Women who are pregnant or nursing. Women who have an IUD that would make imaging unsafe.
• Recent taking of medications that may influence study outcomes (e.g., disulfiram, naltrexone, acamprosate, anticonvulsants).
• Subjects likely to exhibit clinically significant alcohol withdrawal during the study.

Where it is running

• The Anlyan Center, 300 Cedar St. — New Haven, Connecticut, United States (enrolling)
• Yale University — New Haven, Connecticut, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.